Next Generation: Precision Blood Rinsing

A microfluidic device can safely remove glycerol from thawed red blood cells in minutes, potentially making frozen blood more feasible for routine transfusions.

Nov 25, 2014
Molly Sharlach

A digital holographic microscopy image of red blood cellsWIKIMEDA, EGELBERGThe technique: Dialysis with decreasing saline concentrations gently cleanses thawed red blood cells of the toxic cryoprotectant glycerol. This microfluidic approach cuts the time for glycerol removal from an hour down to three minutes, bioengineers Ratih Lusianti and Adam Higgins of Oregon State University reported last month (October 28) in Biomicrofluidics.

The process shields the cells from osmotic shock and lowers the glycerol concentration from 40 percent to 0.4 percent. More than 90 percent of the cells remain intact.

“I think exposing [red blood cells to glycerol] stepwise and smoothly as they did here is a very great approach,” said Utkan Demirci, a bioengineer at Stanford University School of Medicine who was not involved in the study. “This may pave the way for some automated systems in the future.”

The significance: Glycerol, a simple sugar alcohol, protects cryopreserved cells from damage by disrupting the formation of ice crystals. But glycerol must be washed from blood cells before they can be used for transfusions. The existing washing protocol involves a slow series of centrifugations, which limits the utility of frozen blood supplies to transfusions for people with rare blood types, or patients whose own blood is banked prior to planned surgery.  

“I basically recognized that red blood cells are known to be highly permeable to water and molecules like glycerol,” said Higgins. “Yet the current process for washing glycerol out of cryopreserved red blood cells required an hour, and it just didn’t seem like that made a whole lot of sense.”

If adapted for clinical use, the method developed by Higgins and Lusianti could change how blood is stored. Frozen blood can be preserved for 10 years, a vast improvement over the six-week shelf life of refrigerated blood supplies.

What’s new: A computer model allowed Lusianti and Higgins to predict how the volume of red blood cells would respond to changing concentrations of glycerol and sodium chloride, which constrained the rate of glycerol removal. “Because of the use of such a high glycerol concentration, it’s pretty easy to cause osmotic gradients that cause swelling or shrinkage” of the cells, said Higgins.

The researchers first tested the process by manually adding saline solutions to a small, continuously mixing volume of cells, and then constructed a microfluidic device to remove glycerol “conveniently and continuously,” said Higgins. The device has a pair of microchannels 50 or 130 microns wide, separated by the same type of membrane used in kidney dialysis. Red blood cells, which start out in a solution of 40 percent glycerol, are pumped through one of the channels at a rate of about 4 centimeters per second. The microchannel on the other side of the membrane is filled with 5 percent saline, which is gradually decreased to 0.9 percent.

Needs improvement: To achieve a typical blood transfusion flow rate of 4 milliliters per minute would require about 480 parallel microchannels. Higgins and his colleagues plan to work with engineers who specialize in arrayed microfluidics to design a scaled-up device. Another concern is the adequate removal of damaged blood cells from the system, said Higgins.

According the Demirci, glycerol toxicity remains an issue—safer cryoprotectants, he said, could further advance the practice of blood banking. (Demirci and his colleagues have investigated the cryoprotective properties of ectoine, an osmoprotectant molecule produced by bacteria that thrive in high-salt environments.)

Higgins said his group is looking into “a variety of other sexier microfluidic technologies that could potentially be applied to this problem as well,” but added that “the membrane-based device is a nice starting point because it’s pretty simple.”

R.E. Lusianti and A.Z. Higgins, “Continuous removal of glycerol from frozen-thawed red blood cells in a microfluidic membrane device,” Biomicrofluidics, doi:10.1063/1.4900675, 2014.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets


Sponsored Product Updates

Enabling Genomics-Guided Precision Medicine

Enabling Genomics-Guided Precision Medicine

Download this eBook from Qiagen to learn more about the promise of precision medicine and how QCITM Interpret can help deliver better care with better knowledge.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Download this application note from ACEA Biosciences, Inc., to find out how to perform an immunophenotypic analysis of a human blood sample utilizing 13 fluorescent markers using a compact benchtop flow cytometer equipped with 3 lasers!